Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Express Scripts
AstraZeneca
Dow
Moodys

Last Updated: October 18, 2019

DrugPatentWatch Database Preview

Litigation Details for Abbott Laboratories v. Teva Parenteral Medicines Inc. (D. Del. 2009)

See Plans and Pricing

« Back to Dashboard

Abbott Laboratories v. Teva Parenteral Medicines Inc. (D. Del. 2009)

Docket   Start Trial Date Filed 2009-11-19
Court District Court, D. Delaware Date Terminated 2010-10-18
Cause 35:271 Patent Infringement Assigned To Gregory Moneta Sleet
Jury Demand None Referred To Magistrate Judge Karla R. Spau
Parties ABBOTT LABORATORIES; FEDERAL EXPRESS CORPORATION; HARRIS CORPORATION; TEVA PARENTERAL MEDICINES INC.; TEVA PHARMACEUTICAL INDUSTRIES LTD.; TEVA PHARMACEUTICALS USA INC.; WISCONSIN ALUMNI RESEARCH FOUNDATION
Patents 5,246,925; 5,587,497; 6,361,758
Attorneys Brian R. Gilchrist; Charley F. Brown; J. Scott Anderson; Jason S. Jackson; Jeffrey H. Brickman; John C. Phillips , Jr.; Lawrence K. Nodine; Marilyn G. Moran; Mary B. Graham; Richard L. Horwitz; Robin L. Gentry; Ryan Thomas Santurri; Sumner C. Rosenberg
Firms Charley F. Brown; J. Scott Anderson; Jeffrey H. Brickman; Lawrence K. Nodine; Needle & Rosenberg, PC; Robin L. Gentry; Sumner C. Rosenberg
Link to Docket External link to docket
Small Molecule Drugs cited in Abbott Laboratories v. Teva Parenteral Medicines Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Abbott Laboratories v. Teva Parenteral Medicines Inc. (D. Del. 2009)

Date Filed Document No. Description Snippet Link To Document
2009-11-19 1 infringement of U.S. Patent Nos. 5,246,925 (“the ’925 patent”); 5,587,497 (“the ’497 patent”); and 6,136,799…civil action for patent infringement and declaratory judgment arising under the patent laws of the United… the United States Patent and Trademark Office (“the PTO”) issued the ’925 patent, entitled “19-nor-Vitamin…the exclusive licensee of the ’925 patent. A copy of the ’925 patent is attached hereto as Exhibit A. …the exclusive licensee of the ’497 patent. A copy of the ’497 patent is attached hereto as Exhibit B. External link to document
2010-02-18 14 declaration of non-infringement of United States Patent No. 6,361,758; Count 2 of the Counterclaims of Teva Pharmaceuticals…declaration of invalidity of United States Patent No. 6,361,758; Count l of the Counterclaims of Teva Parenteral…declaration of non-infringement of United States Patent No. 6,361,758; and Count 2 of the Counterclaims of Teva…declaration of invalidity of United States Patent No. 6,361. ,758 hereby are DISMISSED WITHOUT PREJUDICE…2009 18 October 2010 1:09-cv-00884 830 Patent None District Court, D. Delaware External link to document
2009-11-20 3 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,246,925; 5,587,497; 6,136,799…2009 18 October 2010 1:09-cv-00884 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Express Scripts
Harvard Business School
Johnson and Johnson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.